2024 NHLBI Workshop Charts Promising Future Directions for ECMO-Induced Coagulopathy
Jerrold Levy, MD, Critical care physician in CTICU, Duke University School of Medicine, recently shared an insightful post on X:
”ECMO-induced coagulopathy: strategic initiatives for research and clinical practice (workshop NHLBI report). This open access 2024 summary is online and new ASH journal (BLOODVTH) not on PubMED yet. Extracorporeal Life Support Organization (ELSO) please share with your community.”
Read the full article here.
The NHLBI hosted a May 2024 workshop on ECMO-induced coagulopathy, uniting experts to tackle anticoagulation challenges and advance precision medicine approaches.
The event highlighted research gaps, innovative therapies, and opportunities for interdisciplinary collaboration to improve patient outcomes.
More news on scientific advancements in Hemostasis Today.
-
Apr 23, 2026, 14:52Anticoagulation Management and Outcomes in Patients with Cancer-Associated Small Venous Thromboembolism – JTH
-
Apr 23, 2026, 14:46Mital Jhaveri: Anticoagulant Approval and Uptake Timeline
-
Apr 23, 2026, 14:42Salih Ehsan: Bradykinin-Mediated Transfusion Reactions in Patients on ACE Inhibitors
-
Apr 23, 2026, 14:39Mona Alfaraj: Don’t Miss the Chance to Be Part of the 2nd International Hematology and Hemostasis Conference
-
Apr 23, 2026, 14:11Emerging Contributions to Hemostasis from Recipients of the Christine Lee Young Researcher Awards – WFH
-
Apr 23, 2026, 13:52Joffrey Feriel: A Revised ISTH Definition of Disseminated Intravascular Coagulation
-
Apr 23, 2026, 13:39Mazou Ngou Temgoua: Cancer and VTE – Toward Truly Personalized Anticoagulation
-
Apr 23, 2026, 13:35Jecko Thachil: Risk Assessment and Clinical Management of Nephrotic Syndrome–Associated Thrombosis
-
Apr 23, 2026, 12:18Mona Ranade: A Contemporary Framework for Managing Right Heart Thrombus in PE